General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Pfizer(MODEST), Eidos(MODEST), AstraZeneca Pharmaceuticals(MODEST), Eidos/BridgeBio(MODEST), Intellia(MODEST), Novo Nordisk Inc.(SIGNIFICANT), Lumanity(MODEST) RESEARCH/RESEARCH GRANTS: Eidos(NONE), Pfizer Inc(SIGNIFICANT)

View Full Disclosure